Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedNov 21, 2024
DataAggregated Company Financials
Companies20
  • 7D-2.4%
  • 3M-18.6%
  • 1Y5.8%
  • YTD5.9%

Over the last 7 days, the Healthcare industry has dropped 2.4%, driven by a pullback from Novo Nordisk of 2.4%. Meanwhile, Gubra actually outperformed within the industry, gaining 29% in the last week. This takes the industry's 12 month performance to a gain of 5.8%. Earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 Nov 2024DKK 3.8tDKK 387.3bDKK 111.3b33.1x34.3x9.9x
Sat, 19 Oct 2024DKK 4.2tDKK 372.1bDKK 107.2b37.1x38.8x11.2x
Mon, 16 Sep 2024DKK 4.7tDKK 372.0bDKK 107.1b36x43.8x12.6x
Wed, 14 Aug 2024DKK 4.7tDKK 370.3bDKK 106.9b36.3x43.5x12.6x
Fri, 12 Jul 2024DKK 4.9tDKK 355.3bDKK 106.2b35.8x46x13.8x
Sun, 09 Jun 2024DKK 4.9tDKK 355.3bDKK 106.2b36.2x46.5x13.9x
Tue, 07 May 2024DKK 4.4tDKK 354.8bDKK 106.4b34.2x40.9x12.3x
Thu, 04 Apr 2024DKK 4.5tDKK 341.2bDKK 99.6b37.8x45.2x13.2x
Sat, 02 Mar 2024DKK 4.4tDKK 340.0bDKK 98.9b38x44.4x12.9x
Mon, 29 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b34.7x42x11.8x
Wed, 27 Dec 2023DKK 3.6tDKK 320.4bDKK 90.0b32.7x40.2x11.3x
Fri, 24 Nov 2023DKK 3.7tDKK 320.5bDKK 90.0b32.5x40.8x11.4x
Sun, 22 Oct 2023DKK 3.5tDKK 305.5bDKK 82.2b27.8x42.6x11.5x
Tue, 19 Sep 2023DKK 3.4tDKK 305.5bDKK 82.2b36.1x41.9x11.3x
Thu, 17 Aug 2023DKK 3.4tDKK 302.9bDKK 81.1b38.5x41.4x11.1x
Sat, 15 Jul 2023DKK 2.9tDKK 286.9bDKK 75.4b39x38.6x10.1x
Mon, 12 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b40x39.9x10.5x
Wed, 10 May 2023DKK 3.1tDKK 284.1bDKK 74.5b39.9x42.2x11.1x
Fri, 07 Apr 2023DKK 3.0tDKK 272.4bDKK 68.5b39.4x43.5x10.9x
Sun, 05 Mar 2023DKK 2.8tDKK 292.6bDKK 69.2b39.4x40.7x9.6x
Tue, 31 Jan 2023DKK 2.7tDKK 275.9bDKK 66.3b37.2x40.9x9.8x
Thu, 29 Dec 2022DKK 2.6tDKK 276.1bDKK 66.3b36.6x40x9.6x
Sat, 26 Nov 2022DKK 2.5tDKK 276.2bDKK 66.3b36.6x37.8x9.1x
Mon, 24 Oct 2022DKK 2.3tDKK 261.3bDKK 62.4b34.9x36.9x8.8x
Wed, 21 Sep 2022DKK 2.2tDKK 261.2bDKK 62.4b33.1x35.3x8.4x
Fri, 19 Aug 2022DKK 2.3tDKK 258.9bDKK 62.7b33.9x36.7x8.9x
Sun, 17 Jul 2022DKK 2.5tDKK 247.9bDKK 59.9b37.4x41.2x9.9x
Tue, 14 Jun 2022DKK 2.3tDKK 247.7bDKK 59.9b34.8x37.8x9.1x
Thu, 12 May 2022DKK 2.2tDKK 247.1bDKK 60.6b33.9x36.5x8.9x
Sat, 09 Apr 2022DKK 2.5tDKK 238.0bDKK 59.8b39.3x42.3x10.6x
Mon, 07 Mar 2022DKK 2.2tDKK 238.0bDKK 59.7b36.6x36.6x9.2x
Wed, 02 Feb 2022DKK 2.2tDKK 229.7bDKK 57.8b42.2x37.3x9.4x
Fri, 31 Dec 2021DKK 2.4tDKK 229.2bDKK 57.8b52.7x41.6x10.5x
Sun, 28 Nov 2021DKK 2.3tDKK 229.2bDKK 57.8b53.3x40.4x10.2x
Price to Earnings Ratio

40.4x


Total Market Cap: DKK 2.3tTotal Earnings: DKK 57.8bTotal Revenue: DKK 229.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 40.6x202220232024
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 34.3x which is lower than its 3-year average PE of 40.6x.
  • The industry is trading close to its 3-year average PS ratio of 10.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 24% per year over the last three years.
  • Revenues for these companies have grown 19% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market-0.95%
Healthcare-2.40%
Life Sciences11.98%
Healthcare Services10.20%
Medical Equipment-0.27%
Pharma-2.34%
Healthtech-2.37%
Biotech-8.58%
Industry PE
  • Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 93.7x.
    • Analysts are expecting annual earnings growth of 17.2%, which is higher than its past year's earnings decline of 23.7% per year.
  • Investors are most pessimistic about the Biotech industry, which is trading below its 3-year average of 226x.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 48% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EMBLA Embla Medical hfDKK 36.302.8%
+DKK 426.9m		33.0%PE31.5x
HLUN B H. LundbeckDKK 45.000.3%
+DKK 119.0m		35.4%PE16.6x
VIRO ViroGatesDKK 16.5016.2%
+DKK 17.8m		102.2%PS17.6x
STENO StenocareDKK 2.1867.7%
+DKK 17.6m		-34.7%PS19.5x
SMSMED Scandinavian Medical SolutionsDKK 6.385.6%
+DKK 9.4m		-18.6%PE22.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SMSMED

DKK 6.38

Scandinavian Medical Solutions

7D

5.6%

1Y

-18.6%

HLUN B

DKK 45.00

H. Lundbeck

7D

0.3%

1Y

35.4%

We Think H. Lundbeck's (CPH:HLUN B) Solid Earnings Are Understated

Nov 21
We Think H. Lundbeck's (CPH:HLUN B) Solid Earnings Are Understated

NOVO B

DKK 721.80

Novo Nordisk

7D

-3.9%

1Y

1.8%

ALK B

DKK 154.70

ALK-Abelló

7D

-8.6%

1Y

64.7%

Results: ALK-Abelló A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 17
Results: ALK-Abelló A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

COLO B

DKK 873.20

Coloplast

7D

-4.4%

1Y

13.2%

ZEAL

DKK 697.00

Zealand Pharma

7D

-13.0%

1Y

113.8%

AMBU B

DKK 110.85

Ambu

7D

-9.4%

1Y

22.9%

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13
Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

GMAB

DKK 1,447.50

Genmab

7D

-4.6%

1Y

-32.4%

VIRO

DKK 16.50

ViroGates

7D

16.2%

1Y

102.2%

STENO

DKK 2.18

Stenocare

7D

67.7%

1Y

-34.7%

DEMANT

DKK 258.00

Demant

7D

-3.2%

1Y

-7.5%

Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return

Nov 05
Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return

EMBLA

DKK 36.30

Embla Medical hf

7D

2.8%

1Y

33.0%

Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

Oct 25
Results: Embla Medical hf. Beat Earnings Expectations And Analysts Now Have New Forecasts

GUBRA

DKK 606.00

Gubra

7D

-11.7%

1Y

425.9%